Medical Devices

Lee Feldman, Bill Haulbrook, Andrea Robidoux
Charlie Johnson

Wide Range of Medical Device Clients

ACT Medical
Aerogen Ireland
AeroSurgical
Agilent Technologies
Cadent Medical Corporation
Cambridge Heart
CardioLogic Systems
Clinical Data
Convergent Radiotherapy
Creagh Medical
Facet Solutions
Harvest Technologies    
GeNO
GI Dynamics
Infusion Dynamics
Intelligent Hearing Systems
IZI Medical Products
LightLab Imaging
Microflex
Modular Genetics
NeuroLogica Corp
Physiometrix
Proxy Biomedical    
Osteotech
Quantum Medical Imaging
SafeGard Medical Products
Sapidyne Instruments
Siemens Medical Solutions
Smith & Nephew
Tegra Medical
Tillotson Corporation
Union Biometrica
VivaScan
Vivasure Medical
Vysera Biomedical

Leader in Venture Capital

Facilitating introductions and highly knowledgeable in equity financings through representation of preeminent venture capital firms, including:

Advent International
Ampersand Ventures
Argo Global Capital
Ascent Venture Partners
Atlas Venture Fund
Battery Ventures
BCE Capital
Bessemer Venture Partners
BioVentures Investors
Boston Millennia Partners
Cardinal Health Partners
Celtic House
Essex Woodlands
Fidelity Ventures
Flagship Ventures
General Catalyst
GrandBanks Capital
Highland Capital Partners
IDG Ventures
Kodiak Venture Partners
MedEquity
North Bridge
Oxford Bioscience
Polaris Ventures
Prism Venture Partners
Summit Partners
VenGrowth

Industry Experts

Lawyers have negotiated key strategic partnerships, licenses, joint ventures, r&d agreements, distributorships and commercial transactions with industry leaders, including:

 

Abbott Laboratories
Baxter Healthcare
Chiron
Dow Chemicals
EtnaVax
Heska
Intermune
Monsanto
Pfizer
Pharmacia

Premier Healthcare Practice

Lawyers represent many flagship first-users of new medical devices engaged in their research, testing and licensing, including:

 

Beth Israel Hospital
Brigham & Women’s
Children’s Hospital Boston
Dana Farber
Harvard Medical School
Mass General Hospital
Memorial Sloan-Kettering
South Shore Hospital

  • toggle

    Choate represented Canaccord Genuity in connection with a $77 million registered direct offering by Dexcom, a company that provides continuous glucose monitoring for people with diabetes, and a $52 million initial public offering by IMRIS, which provides the VISIUS Surgical Theatre that delivers intraoperative vision to clinicians.

  • toggle

    Choate represented Harvest Technologies in connection with its sale to Terumo of Japan.  Harvest provides the SmartPReP system that is specifically designed for the rapid preparation of autologous platelet concentrates.

  • toggle

    Choate represented LightLab Imaging in connection with its sale to St. Jude Medical.  LightLab, which specializes in optical imaging technology for studying cardiac issues, was a subsidiary of Japan’s Goodman Co. Ltd.

 

Medical Devices

Medical Device Company Specialty

Representing leading medical device companies in their entire life cycle from start-up to public company to M&A.

Emerging Companies Expertise

Lawyers have organized several thousand emerging companies.

Transaction Powerhouse

High-level transaction experience to assist medical device companies in all capital needs through all stages of growth:

Public company securities offerings with proceeds over $17 billion
Mergers and acquisitions with value over $50 billion
Venture financings with proceeds over $5.6 billion
(since 2000)

Bench Strength

70 lawyers representing medical device companies.  Lawyers throughout practice areas consistently receive national recognition for excellence.

Full Range of IP Services

Full range of services, including strategic IP counseling; patent prosecution; trademark prosecution; copyright protection; and trade secrets and unfair competition counseling.  One of first major Boston firms to establish patent group.  Sophisticated IP due diligence for investors and acquirers.  Decades of litigation experience in IP disputes.

World-Class Licensing Capability

Among most experienced and knowledgeable licensing lawyers in US in all areas including open source.

Capital Market Leader

Lawyers have represented blue chip underwriters and investment bankers, including:

Bank of America Merrill Lynch

Needham & Co.

Canaccord Genuity

SG Cowen Securities

Deutsche Bank

Stifel Nicolaus Weisel

JP Morgan Chase

UBS Securities

Morgan Stanley

William Blair

National/International Reach

Medical device company transactions across US and abroad.
Preeminent US – Canada cross-border practice.

National Recognition

  • Ranked among the top “Most Active Law Firms” worldwide based on number of private equity and venture capital deals negotiated and closed in 2011 (Private Equity Analyst)
  • Ranked among the top “Most Active Law Firms” worldwide based on number of private equity and venture capital funds worked on for general partners and limited partners that closed in 2011 (Private Equity Analyst)

Leading US Law Firm

One of nation’s leading law firms for over a century.

 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline